Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Non-compliance with PCOS medication worsens symptoms and highlights the need for better patient support and education.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Ayurvedic treatment and Yoga Basti therapy improved a woman's PCOS symptoms.

Eating junk food is linked to higher rates of PCOS and related symptoms in women.

PCOS management includes lifestyle changes and medications to improve fertility.

A woman with PCOS successfully overcame secondary infertility and became pregnant with triplets after treatment.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.